Acesso livre
Acesso livre

Transplante – Medula Óssea

5 principais desafios da gestão de antibióticos em doenças infecciosas relacionadas a transplante e estratégias práticas para abordá-las.

2 Mai, 2022 | 13:55h

Bring it on: Top five antimicrobial stewardship challenges in transplant infectious diseases and practical strategies to address them – Antimicrobial Stewardship & Healthcare Epidemiology

 

Comentário no Twitter

Sob licença de http://creativecommons.org/licenses/by/4.0/


Índice de estresse e ativação endotelial (EASIX – endothelial activation and stress index) pré-transplante pode predizer danos causados por sepse após transplante alogênico de células-tronco.

21 Abr, 2022 | 11:30h

Pre-transplant EASIX and sepsis after allogeneic stem cell transplantation – Intensive Care Medicine

 

Comentário no Twitter

 


Um estudo de braço único avaliou o uso de enxerto de células-tronco do sangue periférico com depleção de células T naive para prevenir a doença enxerto-versus-hospedeiro crônica.

20 Jan, 2022 | 21:48h

Naive T-Cell Depletion to Prevent Chronic Graft-Versus-Host Disease – Journal of Clinical Oncology

Comentário: New graft strategy may improve outcomes for blood stem cell recipients – University of Pittsburg


Estudo randomizado | Maribavir para infecções por citomegalovírus refratárias com ou sem resistência pós-transplante.

7 Dez, 2021 | 11:29h

Maribavir for Refractory Cytomegalovirus Infections With or Without Resistance Post-Transplant: Results from a Phase 3 Randomized Clinical Trial – Clinical Infectious Diseases


Diretrizes ASH 2021 para transplante de célula-tronco em pacientes com doença falciforme.

14 Out, 2021 | 10:43h

American Society of Hematology 2021 guidelines for sickle cell disease: stem cell transplantation – Blood

Comunicado de imprensa: ASH Releases New Clinical Practice Guidelines on Stem Cell Transplantation in Sickle Cell Disease

Comentário: ASH Issues Guideline on the Use of HSCT for Sickle Cell Disease – HealthDay


FDA autoriza aplicação de dose adicional da vacina contra Covid-19 em indivíduos imunocomprometidos – As demais pessoas, já plenamente vacinadas, não precisam de dose adicional neste momento.

16 Ago, 2021 | 12:10h

Coronavirus (COVID-19) Update: FDA Authorizes Additional Vaccine Dose for Certain Immunocompromised Individuals – U.S. Food & Drug Administration

Comentários:

Statement on FDA Authorization of Supplemental Vaccine Dose for Immunocompromised Patients – Infectious Diseases Society of America

CDC, FDA recommend COVID booster for immune-compromised – CIDRAP

FDA authorizes additional dose of Covid-19 vaccine for the immunocompromised – STAT

The fine print: Understanding the new policy authorizing extra Covid vaccine doses for the immunocompromised – STAT

Covid booster: US approves third jab for the immunocompromised – BBC

CDC Committee Approves Third Covid-19 Shot For Immunocompromised People—Here’s Who Should Get One – Forbes

CDC Panel Recommends 3rd Vaccine Dose For Immunocompromised People – NPR

6 Things To Know If You’re Immunocompromised And Considering A 3rd Shot – NPR

CDC recommends third Covid-19 vaccine dose for certain immunocompromised people – CNN

 

Comentário no Twitter

 


Estudo randomizado | Ruxolitinibe para doença do enxerto versus hospedeiro refratária a glicocorticoide.

16 Jul, 2021 | 09:45h

Ruxolitinib for Glucocorticoid-Refractory Chronic Graft-versus-Host Disease – New England Journal of Medicine


Mantenha-se atualizado em sua especialidade

 

Escolha quantas especialidades quiser.